Table 1.
Demographic and clinical characteristics
| Parameter | n = 207 | Percentage or range |
|---|---|---|
| Age | 54 ± 8 | 22–72 |
| Gender (M:F) | 142:65 | 69:31 |
| BMI | 30.1 ± 5.7 | 17.4–47.9 |
| MELD score | 21 ± 8 | 6–46 |
| Height | 67 ± 4 | 64–72 |
| Weight | 198 ± 45 | 140–261 |
| Etiology of liver disease | 80 | 38.6 |
| ALD | 51 | 24.6 |
| HCC | 79 | 38.2 |
| HCV | 45 | 21.7 |
| NASH | ||
| Totalbilirubin | 6.3 ± 8 | 0.3–57.9 |
| Creatinine | 1.6 ± 1.4 | 0.33–7 |
| INR | 1.6 ± 0.47 | 1–4 |
| Obesity type 1 | 57 | 27.5 |
| Obesity type 2 | 46 | 22.2 |
| Obesity type 3 | 4 | 2 |
| pre-Lumbar index | 46.25 ± 10.56 | 23.61–74.69 |
| Lumbar index 6 months | 40.72 ± 10.46 | 15.83–68.57 |
| Lumbar index 1 year | 41.51 ± 9.74 | 21.35–68.65 |
| Ascities | 148 | 7.5 |
ALD, alcoholic liver disease; BMI, body mass index; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; MELD, model for end stage liver disease; NASH, nonalcoholic steatohepatitis.